Carmell
OTC: XAGEPittsburgh, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Carmell
Sign up to see every warm intro you have to Carmell
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Carmell team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A cosmetic skincare and haircare company that develops exosome-based and platelet-derived products for professional care providers and retail consumers seeking anti-aging and regenerative solutions. The company manufactures Elevai Exosomes skincare and haircare lines—which contain nano-sized vesicles derived from cultured stem cells—and Carmell Secretome skincare products made from growth factors extracted from allogeneic human platelets, all produced in U.S. facilities under strict regulatory standards.
Founders & leadership
Board
Investors · 1
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6M disclosed across 4 rounds · 2024–2026
▶$200KraisedMar 2026 · 1 investors · Other Health CareRule 506(b)
- Rajiv S. ShuklaExecutive Officer, Director
- Kathryn GregoryDirector
- Janakiram AjjarapuExecutive Officer, Director
- Patrick SturgeonDirector
- Scott FrischDirector
- Bryan CassadayExecutive Officer
- Gilles SpenlehauerDirector
- Richard UptonDirector
- Offering amount
- $200K
- Amount sold
- $200K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$975.5KraisedJan 2025 · 1 investors · Other Health CareRule 506(b)
- Richard UptonDirector
- Scott FrischDirector
- Bryan CassadayExecutive Officer
- Rajiv ShuklaExecutive Officer, Director
- Kathryn GregoryDirector
- Patrick SturgeonDirector
- Gilles S. SpenlehauerDirector
- Offering amount
- $1.1M
- Amount sold
- $975.5K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.9MraisedJan 2025 · 14 investors · Other Health CareRule 506(b)
- Scott FrischDirector
- Kendra Bracken-FergusonExecutive Officer
- Richard UptonDirector
- Patrick SturgeonDirector
- Gilles SpenlehauerDirector
- Kathryn GregoryDirector
- Rajiv S. ShuklaExecutive Officer, Director
- Bryan CassadayExecutive Officer
- Offering amount
- $3.7M
- Amount sold
- $1.9M
- Sales commissions
- $127.9K
- Placement agents
- Arcadia Securities, LLC
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3MraisedApr 2024 · 19 investors · Other Health CareRule 506(b)
- Gilles SpenlehauerDirector
- Kathryn GregoryDirector
- Richard UptonDirector
- Patrick SturgeonDirector
- David AndersonDirector
- Rajiv S. ShuklaExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- Sales commissions
- $212.2K
- Placement agents
- Arcadia Securities, LLC
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Carmell do?
- A cosmetic skincare and haircare company that develops exosome-based and platelet-derived products for professional care providers and retail consumers seeking anti-aging and regenerative solutions. The company manufactures Elevai Exosomes skincare and haircare lines—which contain nano-sized vesicles derived from cultured stem cells—and Carmell Secretome skincare products made from growth factors extracted from allogeneic human platelets, all produced in U.S. facilities under strict regulatory standards.
- Who are Carmell's investors?
- Carmell's investors include Pittsburgh Life Sciences Greenhouse.
- How much funding has Carmell raised?
- Carmell has disclosed $6M raised across 4 rounds.
- Where is Carmell headquartered?
- Carmell is headquartered in Pittsburgh, US.